Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies
C

Proteomic Insights Into Cytokine Release Syndrome and Immune Effector Cell Associated Neurotoxicity Syndrome

By Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies FEATURING Caroline Diorio
By Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies FEATURING Caroline Diorio
45 views
August 14, 2023
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
45:56
Yale Cancer Center

Endocrine Adverse Events From Checkpoint Inhibitors

Feat. K. Herold
11:43
University of Colorado Department of Medicine

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

Feat. L. Kondapalli
29:43
Michigan Medicine

GI and Hepatic Complications of Cancer Immunotherapy

Feat. R. Fontana
19:05
International Congress on Cancer Metastasis

Could We Cure Metastatic Breast Cancer?

Feat. L. Pusztai
67:04
European School of Oncology

Basic Principles of Tumor Immunology

Feat. M. van den Broek
18:46
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

Biomarkers in Immuno-Oncology: Road to Personalized Immunotherapy

Feat. C. Jackson
11:26
ImmunoTherapy Bridge 2023

Bispecific vs. Combination Therapy - PRO Bispecific

Feat. J. Gulley
20:06
ImmunoTherapy Bridge 2023

Bispecific vs. Combination Therapy - PRO Combination Therapy

Feat. A. Patnaik
26:13
Yale Cancer Center

New Strategies for Detecting Early Ovarian and Uterine Cancers

Feat. P. Dottino
20:12
OncoAlert

Geriatric Oncology Updates: Guidelines and Priorities for Older Pati…

Feat. L. Decoster
21:45
International Congress on Cancer Metastasis

Immunotherapy and Targeted Therapy for Personalized Cancer Treatment

Feat. K. Kim
16:02
ImmunoTherapy Bridge 2023

Novel Insights Into the Mechanisms of Radiation-Induced Anti-Tumor I…

Feat. S. Demaria
16:18
ImmunoTherapy Bridge 2023

Innovating Immunotherapy for Pancreatic Cancer

Feat. G. Lesinski
48:12
Yale Cancer Center

Lymphocytes as a "Living Drug" for the Treatment of Cancer

Feat. S. Rosenberg
50:56
UNC Lineberger Comprehensive Cancer Center

2024 Update in Oncologic Emergencies

Feat. J. Stein
30:53
Beth Israel Deaconess Medical Center

The Role of the Intestinal Microbiome in Cancer Immunotherapy

Feat. M. Van Den Brink
21:48
Houston Methodist Hospital

Tumor-Infiltrating Lymphocytes for Clinicians

Feat. S. Ganguly
17:27
Louisville Hematology Highlights

Using Tumor Infiltrating Lymphocytes to Induce Solid Tumor Regression

Feat. J. Chesney
15:09
ImmunoTherapy Bridge 2023

Best of SITC 2023 for Clinical Development and IO Trials

Feat. P. A. Ascierto
12:21
ImmunoTherapy Bridge 2023

Immunotherapy for HCC: Current Status & Future Perspectives

Feat. P. Federico